Antioedematogenic and antinociceptive actions of NPC 18521, a novel bradykinin B2 receptor antagonist
- 1 December 1996
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 316 (2-3) , 277-286
- https://doi.org/10.1016/s0014-2999(96)00661-9
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Synthesis and Characterization of Pseudopeptide Bradykinin B2 Receptor Antagonists Containing the 1,3,8-Triazaspiro[4.5]decan-4-one Ring SystemJournal of Medicinal Chemistry, 1996
- Expression of B1 kinin receptors mediating paw edema and Formalin-induced nociception. Modulation by glucocorticoidsCanadian Journal of Physiology and Pharmacology, 1995
- Bradykinin and inflammatory painTrends in Neurosciences, 1993
- Human Bradykinin B2 Receptor: Nucleotide Sequence Analysis and Assignment to Chromosome 14Genomics, 1993
- Molecular cloning, functional expression and pharmacological characterization of a human bradykinin B2 receptor geneBiochemical and Biophysical Research Communications, 1992
- Biochemical and Molecular Pharmacology of Kinin ReceptorsAnnual Review of Pharmacology and Toxicology, 1992
- Cloning and pharmacological characterization of a human bradykinin (BK-2) receptorBiochemical and Biophysical Research Communications, 1992
- Eosinophil Accumulation in the Rat Pleural Cavity after Mast Cell Stimulation with Compound 48/80 Involves Protein Synthesis and Is Selectively Suppressed by DexamethasoneInternational Archives of Allergy and Immunology, 1990
- Interaction of Bradykinin with Substance P on Vascular Permeability and Pain ResponseThe Japanese Journal of Pharmacology, 1986
- Ethical guidelines for investigations of experimental pain in conscious animalsPAIN®, 1983